FdaApplication
NDA 215441
Identifiers
- fda_app_no: NDA215441
Properties
| Property | Value |
|---|---|
| applicant_name | ACCORD HEALTHCARE INC |
| application_type | NDA |
| approval_date | 2022-07-26 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BORTEZOMIB | BORTEZOMIB | 3.5MG/1.4ML (2.5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION;INTRAVENOUS |
| BORTEZOMIB | BORTEZOMIB | 2.5MG/ML (2.5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION;INTRAVENOUS |
2 products